1. Search Case laws by Section / Act / Rule β now available beyond Income Tax. GST and Other Laws Available


2. New: βIn Favour Ofβ filter added in Case Laws.
Try both these filters in Case Laws β
Just a moment...
1. Search Case laws by Section / Act / Rule β now available beyond Income Tax. GST and Other Laws Available


2. New: βIn Favour Ofβ filter added in Case Laws.
Try both these filters in Case Laws β
Press 'Enter' to add multiple search terms. Rules for Better Search
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
<h1>Appellate Tribunal upholds Ranitidine Injection classification under CET</h1> The Appellate Tribunal CEGAT, Mumbai upheld the classification of Ranitidine Injection under CET sub-heading 3003.20 as claimed by the respondent, ... Medicament - Ranitidine Injection affixed with word βGlaxoβ The Appellate Tribunal CEGAT, Mumbai upheld the classification of Ranitidine Injection under CET sub-heading 3003.20 as claimed by the respondent, rejecting the Revenue's appeal. The Tribunal found that the use of the word 'Glaxo' on the label did not establish a relationship between the word and the medicine, considering it a house mark as per the Drugs Rules. The decision was based on the judgment of the Supreme Court in Astra Pharmaceuticals Pvt. Ltd. v. CCE [1995 (75) E.L.T. 214 (S.C.)].